Is NRBO or RYLD a better dividend investment in 2026?

NRBO currently yields 84.75% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: NRBO offers higher current income.

What is the dividend yield difference between NRBO and RYLD?

NRBO has a forward dividend yield of 84.75% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 72.61 percentage points.

Home › Compare › NRBO vs RYLD

NRBO vs RYLD: Dividend Comparison 2026

NRBO yields 84.75% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NRBO wins by $2.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NRBO

● Live price

84.75%

Share price

$2.36

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2.05M

Annual income

$615,863.14

Full NRBO calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — NRBO vs RYLD

📍 NRBO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NRBO	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NRBO + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NRBO pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NRBO

Annual income on $10K today (after 15% tax)

$7,203.39/yr

After 10yr DRIP, annual income (after tax)

$523,483.67/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, NRBO beats the other by $521,284.42/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NRBO + RYLD for your $10,000?

NRBO: 50%RYLD: 50%

100% RYLD50/50100% NRBO

Portfolio after 10yr

$1.04M

Annual income

$309,225.24/yr

Blended yield

29.59%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on NRBO right now

NRBO

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-20.1

Piotroski

0/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NRBO buys

RYLD buys

No recent congressional trades found for NRBO or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNRBORYLD

Forward yield	84.75% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2.05M	$44.5K ✓
Annual income after 10y	$615,863.14 ✓	$2,587.35
Total dividends collected	$1.79M	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: NRBO vs RYLD ($10,000, DRIP)

Year	NRBO Portfolio	NRBO Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$19,175	$8,474.58	$11,914	$1,213.65	+$7.3K → NRBO
2	$35,703	$15,186.58	$14,099	$1,351.30	+$21.6K → NRBO
3	$64,630	$26,427.72	$16,580	$1,494.55	+$48.0K → NRBO
4	$113,864	$44,709.84	$19,384	$1,642.61	+$94.5K → NRBO
5	$195,450	$73,615.70	$22,535	$1,794.70	+$172.9K → NRBO
6	$327,228	$118,096.19	$26,063	$1,950.00	+$301.2K → NRBO
7	$534,919	$184,784.73	$29,995	$2,107.69	+$504.9K → NRBO
8	$854,669	$282,305.61	$34,361	$2,266.99	+$820.3K → NRBO
9	$1,336,042	$421,546.65	$39,194	$2,427.12	+$1.30M → NRBO
10	$2,045,428	$615,863.14	$44,525	$2,587.35	+$2.00M → NRBO

NRBO vs RYLD: Complete Analysis 2026

NRBO — Stock

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.

Full NRBO Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this NRBO vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NRBO vs SCHD NRBO vs JEPI NRBO vs O NRBO vs KO NRBO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.